|
Volumn 31, Issue 3, 1998, Pages 494-496
|
Thrombolytic therapy and equivalence trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LANOTEPLASE;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
UNCLASSIFIED DRUG;
ANGIOGRAPHY;
BIOEQUIVALENCE;
BLOOD CLOT LYSIS;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
EDITORIAL;
FIBRINOLYSIS;
HUMAN;
PRIORITY JOURNAL;
ST SEGMENT ELEVATION;
CEREBROVASCULAR DISORDERS;
FIBRINOLYTIC AGENTS;
HUMANS;
MYOCARDIAL INFARCTION;
PLASMINOGEN ACTIVATORS;
RANDOMIZED CONTROLLED TRIALS;
RECOMBINANT PROTEINS;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
URINARY PLASMINOGEN ACTIVATOR;
|
EID: 0032032461
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(97)00551-2 Document Type: Editorial |
Times cited : (26)
|
References (23)
|